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Abstract
The major mechanisms of gallstone formation include biliary cholesterol hypersecretion, supersaturation and crystallization, mucus hypersecre-
tion, gel formation and bile stasis. Gallbladder hypomotility seems to be a key event that triggers the precipitation of cholesterol microcrystals
from supersaturated lithogenic bile. Telocytes, a new type of interstitial cells, have been recently identified in many organs, including gallblad-
der. Considering telocyte functions, it is presumed that these cells might be involved in the signalling processes. The purpose of this study was
to correlate the quantity of telocytes in the gallbladder with the lithogenicity of bile. Gallbladder specimens were collected from 24 patients who
underwent elective laparoscopic cholecystectomy for symptomatic gallstone disease. The control group consisted of 25 consecutive patients
who received elective treatment for pancreatic head tumours. Telocytes were visualized in paraffin sections of gallbladders with double immuno-
fluorescence using primary antibodies against c-Kit (anti-CD117) and anti-mast cell tryptase. Cholesterol, phospholipid and bile acid levels were
measured in gallbladder bile. The number of telocytes in the gallbladder wall was significantly lower in the study group than that in the control
group (3.03  1.43 versus 6.34  1.66 cell/field of view in the muscularis propria, P < 0.001) and correlated with a significant increase in the
cholesterol saturation index. The glycocholic and taurocholic acid levels were significantly elevated in the control subjects compared with the
study group. The results suggest that bile composition may play an important role in the reduction in telocytes density in the gallbladder.
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Introduction
Gallstone disease occurs in 10–15% in adults in Europe and the Uni-
ted States of America and is one of the most common and most
expensive of the digestive disorders that require hospital admission
[1, 2]. In developed countries, cholesterol gallstones account for
80–90% of the gallstones found at cholecystectomy [3]. The aetiol-
ogy of gallstone disease is considered to be multifactorial, with roles
for both genetic and environmental factors [4, 5]. The main mecha-
nisms of cholesterol lithogenesis include biliary cholesterol hyperse-
cretion, supersaturation and crystallization, stone formation and
growth, bile stasis and mucus hypersecretion and gel formation
within the gallbladder. Gallbladder hypomotility may be a key factor in
the pathogenesis of cholelithiasis because it allows time for choles-
terol microcrystals to precipitate from lithogenic bile that is supersat-
urated with cholesterol [6–8]. The impaired gallbladder motility
observed in vivo in a subset of patients with gallstones correlates well
with the decreased in vivo contractility of both gallbladder strips and
isolated gallbladder smooth muscle cells [9, 10].
In recent years, our understanding of the physiology and regula-
tory mechanisms of smooth muscle tissue and the role of interstitium
has been enhanced by the study of a population of newly described
cells, the so-called interstitial Cajal – like cells (ICLCs). Such name
was adopted, as these cells were thought to represent the phenotypic
similarity (at least by means of immunohistochemistry, as they
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expressed c-Kit marker – CD117) to the archetypal, enteric interstitial
cell of Cajal (ICC). Characteristic feature of ICLCs was the small, trian-
gular-shaped body, and the presence of several very long prolonga-
tions. Multiple research teams have identified such cells in various
tissues outside of the gut [11], including the pancreas [12], lungs
[13], heart [14], skin [15], skeletal muscle [16], parotid gland [17],
meninges and the choroid plexus [18], ureter, urethra, urinary bladder
[19, 20], kidney [21], blood vessels [22], male [23, 24] and female
reproductive organs [25–28], mammary glands [29, 30] and placenta
[31]. During the last 5 years Prof. Popescu with his teammates exam-
ined such cells and little by little, it became clear that the ultrastruc-
ture of ICLCs was different from that of ICCs, and that the difference
between these cells was not only semantic, as they have different
ultrastructural and immunophenotypic patterns, and therefore these
cells should be functionally distinct as well [32].
To distinguish ICLCs and to avoid confusion from other interstitial
cell type, i.e. fibroblasts, fibrocytes, fibroblast-like cells, or mesenchy-
mal cells, a new name was coined as telocytes (TCs) to replace ICLCs,
according to the morphological characteristics through immunohisto-
chemistry and electron microscopy [32]. Because in Greek affix ‘telos’
means ‘goal,’ ‘end’, and ‘fulfillment’, the extremely long but thin
prolongations of TCs was named as telopodes (Tps). The concept of
TCs has been currently adopted by other laboratories.
Telocytes were recently discovered in the wall of the human gall-
bladder by Hinescu et al. [33] and in bile ducts by Ahmadi et al. [34].
To date, there has been no direct evidence that TCs are directly
involved in the regulation of gallbladder motility. However, a decrease
in the density of TCs in the muscle layer of the gallbladder could be
hypothetically related to bile stasis and thus might contribute to
gallstone formation, because TCs are suggested to be involved in
signalling processes [14, 16]. Previously, we reported a significant
decrease in c-Kit – positive cells density (TCs) in the gallbladder wall
in patients suffering from gallstone disease [35]. The purpose of this
study was to determine whether telocyte loss was related to the
degree of bile lithogenicity, which was expressed as a lithogenic index
(cholesterol saturation index, CSI), or to the difference in bile salt
profiles in patients who suffer from cholecystolithiasis and those who
are not affected by this disease.
Materials and methods
Subjects
Twenty-four consecutive patients with symptomatic gallstone disease
were scheduled for elective surgery (laparoscopic cholecystectomy) and
selected for the study group (eight men, mean age 52.4  11.7 years;
16 women, mean age 54.9  16.1 years). Patients with gallstones had
detectable calculi in the gallbladder on ultrasound examination before
the operation. They presented with mild, recurrent episodes of biliary
colic. None of these patients had associated choledocholithiasis or acute
cholecystitis. The control group consisted of 25 consecutive patients
(11 men, mean age 62.0  7.6 years; 14 women, mean age
61.0  9.8 years), who were electively treated for pancreatic head
tumours and had no pre- or intraoperative signs of cholelithiasis or
jaundice. Pancreaticoduodenectomy was performed according to the
standard Whipple procedure or the pylorus-sparing Traverso-Longmire
technique in patients with resectable lesions. For patients with non-
resectable lesions, bypass (gastroenterostomy) was carried out for palli-
ative purposes. Gallbladders that were not affected by primary tumours
and did not contain any gallstones were removed. Serum bilirubin levels
were measured pre-operatively and were normal in both groups. All
patients were surgically treated in the First Department of General,
Oncological and Gastrointestinal Surgery at the Jagiellonian University
Medical College from 2010 to 2011.
Ethical approval
The study was conducted in accordance with the moral, ethical, regula-
tory and scientific principles governing clinical research. All surgical
samples were retrieved with the approval of the Jagiellonian University
Bioethical Committee using procedures that conformed to the Declara-
tion of Helsinki guidelines (protocol number – KBET/30/B/2010).
Tissue processing
Tissue samples from fresh cholecystectomy specimens were collected
and rinsed thoroughly with PBS (phosphate-buffered saline, 0.01 M,
pH = 7.4), fixed in 4% phosphate-buffered paraformaldehyde, routinely
processed and embedded in paraffin. Serial sections were cut and
mounted on poly-L-lysine-coated glass slides and stained with haemat-
oxylin and eosin (H&E) for routine histopathology.
Immunohistochemistry
Indirect double immunofluorescence after heat-induced epitope retrieval
was used to allow the simultaneous visualization of two antigens. The
sections were incubated overnight with a mixture of rabbit polyclonal
anti-c-Kit antibody (anti-CD117; A4502; Dako, Glostrup, Denmark;
diluted 1:150) and mouse monoclonal anti-mast cell tryptase antibody
(M7052; Dako; 1:800) or a mouse monoclonal anti-CD34 antibody
(NCL-ENDO; Novocastra, Newcastle, UK; 1:50). The sections were
rinsed in PBS and incubated for 1 hr at room temperature with a mix-
ture of a Cy3-conjugated goat anti-rabbit antibody (111-165-144; Jack-
son ImmunoResearch, West Grove, PA, USA; 165-144; 1:600) and a
biotinylated goat anti-mouse antibody (115-065-146; Jackson IR;
1:600). After washing in PBS, the slides were incubated with DTAF-con-
jugated streptavidin (016-010-084; Jackson IR; 1:500 in PBS) for 1 hr.
After a final rinse in PBS, the nuclei were counterstained with DAPI
(D9542; Sigma-Aldrich, St. Louis, MO, USA; 1:30,000) for 30 sec. The
sections were mounted in Vectashield medium (H-1000; Vector Labora-
tories, Burlingame, CA, USA) to minimize fluorophores photobleaching.
Microscopic examination and quantification of
telocytes
Slides were examined using an Olympus BX50 epifluorescence micro-
scope (Olympus, Tokyo, Japan) equipped with an Olympus DP71 digital
CCD camera. The use of mast cell tryptase staining enabled c-Kit-posi-
tive mast cells to be distinguished from telocytes. The distribution of
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TCs in the gallbladder corpus was quantitatively assessed. TCs were
considered to be c-Kit positive and tryptase negative concurrently.
These cells were counted in 10 consecutive high-power fields (4009).
The data are expressed as the mean number of cells per 1 field of view
(FOV) of gallbladder muscularis propria. The thickness of the muscular-
is propria in the same region of the gallbladder was also measured
using image analysis software (Multiscan v.18, Computers Scanning
System, Warsaw, Poland).
Gallbladder bile collection, sample analysis and
CSI calculation
Bile specimens were obtained from all subjects by needle aspiration of
the gallbladder during surgery. Aliquots of bile samples were stored at
70°C prior to biliary lipid composition analysis. The cholesterol and
phospholipid concentrations and bile acid levels in the bile samples
were determined.
The bile samples were extracted on SEP-PACK-NH2 columns
(500 mg; Waters, Milford, MA, USA). Each column was first activated
using 6 ml of n-hexane; then, 0.1 ml of centrifuged bile sample was
applied to the column, and the flow-through was discarded. The samples
were eluted in three 1-ml volumes of a chloroform-isopropanol mixture
(3:1, v/v), followed by three 1-ml volumes of methanol. The eluted frac-
tions from each column were collected and dried at 50°C under nitrogen.
The dry residues were reconstituted in 0.5 ml of isopropanol and
mixed vigorously. Cholesterol (Randox Laboratories Ltd., Crumlin, UK)
and phospholipid (Wako Chemicals, Neuss, Germany) concentrations
were measured by enzymatic methods. The intra- and interassay coeffi-
cient of variations were 3% and 4.8% for cholesterol and 5% and 6% for
phospholipids, respectively. All determinations were performed with a Co-
bas-Bio analyser (Roche Analytical Instruments, Inc., Nutley, NJ, USA).
Individual bile acids were measured by reverse-phase high-perfor-
mance liquid chromatography with an isocratic solvent system (Waters).
Prior to chromatographic separation, bile acids were extracted from bile
samples using SEP-PACK C18 columns (Waters). All columns were acti-
vated using 5 ml of methanol and 5 ml of water, after which 0.1 ml of
bile mixed with phosphate buffer (0.07 mmol/l, pH 7.0) and 0.1 ml of
internal standard were applied. Then, the columns were washed with
10 ml of water, 3 ml of 10% acetonitrile and another 10 ml of water.
The bile acids were eluted in 3 ml of methanol. The eluates were dried
at 37°C under nitrogen, and dry residues were re-dissolved in 1 ml of
an acetonitrile-water mixture (1:1, v/v). Each sample was filtered using
a Millex GN filter (13 mm) and separated chromatographically using an
XTERRA RPC-18 column (18.5 9 3.9 9 150 mm, Waters) with detec-
tion at 200 nm.
The mobile phase (flow rate 2 ml/min.) contained 10% acetonitrile in
a mixture of methanol and 0.1 M monobasic potassium phosphate
(60:40, v/v, pH 4.50). Before use, the solvent was filtered through a
0.45 lm filter (type HV, Millipore, Bedford, MA, USA). An elution profile
of conjugated bile acid standards (Sigma-Aldrich) was obtained by
injecting 20 ll of a standard bile acid mixture in methanol that con-
tained glycocholic acid (1.640 mmol/l), taurocholic acid (1.488 mmol/l),
glycochenodeoxycholic acid (1.696 mmol/l), glycodeoxycholic acid
(1.696 mmol/l), taurochenodeoxycholic acid (1.532 mmol/l) and tauro-
deoxycholic acid (1.532 mmol/l).
Based on cholesterol, phospholipid and total bile acid concentrations,
the CSI was obtained from Carey’s critical tables [36, 37]. Bile samples
with a CSI equal to 1 or more were considered supersaturated.
Data analysis and statistical evaluation
The data are expressed as the mean and standard deviation (SD). The
results were analysed using a one-way analysis of variance (ANOVA), fol-
lowed by a post-hoc LSD test. Pearson’s correlation test was used to
examine the relationship between continuous variables. P values less
than 0.05 were considered to indicate statistical significance. All statisti-
cal analyses were performed using STATISTICA 9.0 software (StatSoft,
Tulsa, OK, USA).
Results
Histopathological findings
The histopathological evaluations showed chronic cholecystitis of
varying intensity in both groups of patients. The inflammation was
assessed and designated as mild, moderate or severe. In the study
group, severe inflammation was predominant (Fig. 1). In contrast,
only mild to intermediate inflammation was observed in the control
group. The thickness of the gallbladder muscularis propria was signif-
icantly increased in the study group compared with the control group
(4453  597 versus 3610  346 lm; P < 0.01).
The number of mast cells in the gallbladder wall was evaluated in
specimens immunostained for tryptase. Mast cells were present in all
layers of the gallbladder wall and predominantly localized to the lam-
ina propria (Figs 2 and 3). The total number of mast cells in the gall-
bladder wall was significantly higher in patients with gallstones than
in control subjects (224  41 versus 161  37, respectively;
P < 0.05). In immunostained slides, c-Kit and tryptase double-posi-
tive mast cells were generally round or oval shaped, with a centrally
located nucleus.
Fig. 1 Cross section of the gallbladder wall from the cholelithiatic group
showing mild infiltration with inflammatory cells and a thickened
muscular layer. H&E staining. l.p., lamina propria; m.p., muscularis
propria.
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The c-Kit-positive/mast cell tryptase-negative cells were consid-
ered to be telocytes. We found them predominantly located in the cor-
pus, but these cells were also observed in the gallbladder fundus and
neck. TCs had a centrally located nucleus and were mostly fusiform in
shape with small branches, that were visible in some sections; how-
ever, sparse, round tryptase/c-Kit-positive cells were also present.
Numerous TCs were detected, mostly in the muscularis propria, and
some TCs were observed in the connective tissue separating the
smooth muscle bundles (Fig. 1).
The number of TCs in the gallbladder wall corpus was significantly
lower in the study group than that in the control group (3.03  1.43
versus 6.34  1.66 cell/FOV in the muscularis propria; P < 0.001)
(Figs 2 and 3).
CD-34-positive cells were visualized in the gallbladder; however,
they appeared to be mainly of vascular origin. CD-34-positive cells
were rarely encountered in the muscularis propria. These CD-34-posi-
tive cells were c-Kit negative concurrently.
Bile composition analysis
The study revealed a significant decrease in the mean concentrations
of glycocholic and taurocholic acids in the bile from patients with cho-
lelithiasis compared with that in the controls (P < 0.02 and P < 0.05,
respectively) (Fig. 4). There was also a positive correlation between
the TC count and the concentrations of glycocholic (r = 0.45,
P = 0.039) and taurocholic (r = 0.32, P = 0.05) acids.
No significant differences in the concentrations of the other bile
acids examined (glycochenodeoxycholic, glycodeoxycholic, tauroche-
nodeoxycholic and taurodeoxycholic acid) were observed between
the two groups of patients (Fig. 5). There were also no significant
differences in the concentrations of cholesterol, bile salts or phospho-
lipids in the bile between the two groups (Fig. 6).
The calculated CSI was significantly higher in patients with chole-
cystolithiasis (1.23  0.84) than that in the controls (0.78  0.33)
(P < 0.05). Moreover, the results revealed an important negative
correlation (r = 0.62, P = 0.001) between the CSI and the TC count
in the gallbladder wall (Fig. 7A and B).
Discussion
Multiple factors are responsible for gallstone formation. Regardless
of cholesterol supersaturation, hydrophobic bile salts, pronucleating
proteins and mucus hypersecretion with gel formation in the gallbladder
Fig. 2 Cross section of the gallbladder wall of a control patient stained
for CD117 (red) and tryptase (green). The nuclei are counterstained
with DAPI (blue). CD117-positive/tryptase-negative TCs (arrows)
and CD117-positive/tryptase-positive mast cells (arrowheads) are
indicated.
Fig. 3 Cross sections of the gallbladder wall of a cholelithiatic patient
stained for CD117 (red) and tryptase (green). The nuclei are counter-
stained with DAPI (blue). CD117-positive/tryptase-negative TCs (arrows)
and CD117-positive/tryptase-positive mast cells (arrowheads) are indi-
cated.
Fig. 4 Concentrations of glycocholic acid (GCA) and taurocholic acid
(TCA) in gallbladder bile from patients with cholecystolithiasis (n = 24)
and controls (n = 25). The data are expressed as the mean values 
SD.
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[38–41], gallbladder dysmotility may be a ‘triggering’ event in the
pathogenesis of cholesterol gallstones, providing the time necessary
for the precipitation of cholesterol microcrystals from bile supersatu-
rated with cholesterol and their subsequent growth to macroscopic
stones [39, 42]. Gallbladder motility involves multiple regulatory
mechanisms, including smooth muscle and enteric nervous circuit
activity as well as, possibly, the recently described gallbladder inter-
stitial cells—telocytes.
Telocyte is a unique type of interstitial cell with specific prolonga-
tions named Tps [32, 43]. TCs have been described by electron
microscopy in several cavitary and non-cavitary organs of humans
and mammalians forming a 3D network anchored by hetero- and ho-
mocellular junctions. Tps are an alternation of thin segments (podo-
mers) and dilated segments (podoms). Podomers are very thin (less
than 0.2 lm), often below the resolving power of light microscopy,
explaining the fact that TCs have been overlooked up to now. The in-
terstitium (stroma) is in most of the cases seen as a connecting
‘device’ for the specific structures of an organ. Interstitial cells are
usually perceived as being mainly (or even, only) fibroblasts. How-
ever, fibroblasts synthesize connective tissue matrix, i.e. collagen.
The distinction between TCs and fibroblasts is obvious because they
have different ultrastructure and phenotype. Therefore, their functions
should be mostly different: TCs—intercellular signalling (connec-
tions), but fibroblasts—collagen synthesis. In other words, TCs are
‘more’ functionally oriented, and fibroblasts are ‘more’ structurally
oriented, responsible for fibrosis. There are some clear ultrastructural
features that differentiate TCs from fibroblasts. For instance, the gen-
eral aspect of TC is of a small oval (piriform/spindle/triangular/stel-
late)-shaped cellular body, containing a nucleus surrounded by a
small amount of cytoplasm. The shape of the cell body depends on
the number of Tps. Fibroblast cell body is pleomorphic. TC cellular
body average dimensions are, as measured on EM images,
9.3  3.2 lm (min. 6.3 lm; max. 16.4 lm). Fibroblast nucleus is
typically euchromatic, but TC nucleus is mostly heterochromatic.
Mitochondria represent only 2% of cell body volume and the Golgi
complex is small in TC. Fibroblasts Golgi complex is prominent and
Fig. 5 Bile acid concentrations of glycochenodeoxycholic acid (GCDCA),
glycodeoxycholic acid (GDCA), taurochenodeoxycholic acid (TCDCA)
and taurodeoxycholic acid (TDCA) in gallbladder bile from patients with
cholecystolithiasis (n = 24) and controls (n = 25). The data are
expressed as the mean values  SD.
Fig. 6 Concentration of total bile acids (BS), phospholipids (PC) and
cholesterol (Ch) in gallbladder bile from patients with cholecystolithiasis
(n = 24) and controls (n = 25). The data are expressed as the mean
values  SD.
A
B
Fig. 7 Cholesterol saturation index (CSI) (A – upper part) and the
number of TCs (B – lower part) in patients with cholecystolithiasis
(n = 24) and controls (n = 25). The data are expressed as the mean
values  SD.
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the rough endoplasmic reticulum is very well developed (usually
5–12%) of cell volume [44, 45].
Telocytes in the human gallbladder were first described in
gastrointestinal stromal tumours that originated from cells in the
gallbladder wall with an ICC-like phenotype that expressed CD117
[46, 47]. TCs were subsequently identified in several animals. Lavoie
et al. [48] reported the existence of TCs in the guinea pig gallbladder
and described their potential function in electrical coupling in
smooth muscle cells. Balemba et al. [49] described the role of mito-
chondrial Ca2+ handling in the activity of smooth muscle cells and
TCs and underscored the role of TCs in regulating the tone of the
gallbladder in guinea pigs. Huang et al. [50] used whole-mount
preparations of the gallbladder and extrahepatic guinea pig biliary
ducts to identify TCs and suspected the role of such cells in propa-
gation of spontaneous rhythmicity and excitability of the gallbladder.
Xu et al. [51] demonstrated that the cholecystokinin-A receptor on
TCs was essential for gallbladder muscle contractions in guinea pig
muscle strips. Sun et al. [52] successfully identified TCs in the gall-
bladder of CD1 mice using confocal microscopy of whole-mount flat
preparations.
The published data on TCs in the human gallbladder remain lim-
ited. Hinescu et al. [33] reported that TCs in the human gallbladder
typically appeared individually or in small clusters of two to three
cells. According to these authors, the TCs were located in the lamina
propria, with some very close to the epithelium, and in the connective
tissue spaces between bundles of smooth muscle cells. TCs
accounted for 5.5% of the subepithelial cells in the gallbladder wall.
Meanwhile, Ahmadi et al. [34] identified c-Kit-positive cells with char-
acteristic morphology in the subepithelial and muscular layers of the
gallbladder and extrahepatic bile ducts (which are denser than those
of the gallbladder) running parallel to circular smooth muscle fibres,
forming a cellular network. These authors did not find TCs in intrahe-
patic bile ducts.
In this study, TCs within gallbladder wall cross sections were
identified based on anti-c-Kit and anti-tryptase double immunofluo-
rescence to distinguish such cells from mast cells. TCs were predom-
inantly located in the muscularis propria. We expected that the
decrease in TC density in the study group would be related to hyper-
trophy of the muscularis propria. However, there was a significant
(20%) increase in the thickness of the gallbladder wall in the study
group compared with the control group, while the TC count was
reduced by 50%. Surprisingly, this significant loss of TCs in the gall-
bladder wall in patients with gallstones was strongly correlated with
an increased CSI.
Even under physiological conditions, the cholesterol content in
the aqueous solution of gallbladder bile is relatively high because cho-
lesterol is incorporated into mixed micelles, together with bile salts
and phospholipids. When the bile cholesterol levels increase or the
secretion of solubilizing bile salt is diminished, the solution becomes
supersaturated. In this case, excess cholesterol is stored in vesicles
(spheres composed of cholesterol and phospholipids, with no bile
salts), provided that enough phospholipid is available. When relatively
low amounts of phospholipids are present, cholesterol crystal forma-
tion occurs, leading to gallstone formation [8, 39, 53]. Moreover,
cholesterol crystallization is also promoted by hydrophobic bile salts
(e.g. chenodeoxycholate and deoxycholate) and phospholipids with
unsaturated acyl chains [54]. Human bile contains a mixture of both
hydrophobic (e.g. deoxycholate) and hydrophilic (e.g. ursodeoxychol-
ic) acids, and thus, the final hydrophobicity of the bile salts depends
on the relative contents of these components [55–57]. Therefore, the
biliary bile salt composition affects human gallstone formation, which
opens several therapeutic possibilities [58–61]. Our results showed
that there were no significant differences between the two groups of
patients in the mean concentrations of total bile acids, phospholipids,
or cholesterol in vesicular bile, except for the lower mean concentra-
tions of glycocholic and taurocholic acid in the patient group. The
lower amounts of these mostly hydrophilic bile acids were associated
with the increased lithogenicity index (CSI) in the study group. Inter-
estingly, in patients with gallstones, a significant positive correlation
between the mean number of TCs and the concentrations of glyco-
cholic and taurocholic acids was found. We conclude that glycocholic
and taurocholic acids are somehow protective to TCs. However, it is
not clear whether this is an artefact of the statistical analysis or
whether TCs are indeed preserved by these acids, and the exact
mechanism of this possible protective effect should be examined
further, including in an experimental model.
We acknowledge that possible mechanisms underlying the
destructive influence of bile on TCs remain speculative rather than
empiric, as reports on the role of TCs in gallstone pathophysiology
are sparse. Some insights were provided by Hu et al. [62] who dem-
onstrated that the expression of c-Kit mRNA and protein in the gall-
bladder wall was significantly decreased in the gallbladders of guinea
pigs fed a high-cholesterol diet. A study by Xu and Shaffer [9]
reported that gallbladder hypomotility was impaired by the increased
bile cholesterol level. A study by Lavoie et al. [63] proved that excess
cholesterol in the smooth muscle of the gallbladder attenuates the
ability of the muscle to contract as a result of changes in signal trans-
duction and ion channel activity, decoupled membrane receptor–-
ligand interactions and disturbances in contractile protein activity.
Moreover, in a subsequent study on guinea pigs fed a lithogenic diet,
Lavoie et al. [48] reported cholesterol accumulation in gallbladder
smooth muscles in the plasma membrane, especially membrane
caveolae, leading to a decrease in membrane fluidity and a subse-
quent change in rhythmic electric activity. Hypertrophy was also
detected in the muscularis propria, and the contractile response to an
agonist was decreased. It is not yet known whether such mechanisms
could influence TC activity as well. Furthermore, TCs seem not to be
directly involved in the pacemaking mechanism, but rather possibly
act as modulators of the contractility e.g. through the released exo-
somes/shedding vesicles [45]. Elements of the TC network are inter-
acting with each other (homo-cellular connections) as well as with
other cell types (hetero-cellular connections). As reported in the
heart, the homocellular junctions occur at both podomeric and podo-
mic level, either side to side (presumably for exchanging information)
or end to end (probably for relaying, passing on information). Hetero-
cellular junctions are encountered a between TCs and myocytes,
fibroblasts, mast cells, macrophages, pericytes, endothelial or Schw-
ann cells. TCs are integrating such cellular types into a complex 3D
network. These networks are providing both structural and functional
support for long-distance signalling [14, 16, 64].
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Another important mechanism underlying TCs loss concerns the
chronic inflammatory processes involving the gallbladder wall. Por-
tincasa et al. [8] described impaired gallbladder motility caused by
mild inflammation. Indeed, we observed inflammatory infiltration,
predominantly localized in the lamina propria, in the gallbladders of
patients with gallstones, which was associated with a significant
increase in the mast cell count. However, as we reported previ-
ously, TC loss does not correlate with inflammatory grade or mast
cell count [35].
Nevertheless, other indirect inflammatory effects on gallbladder
TCs cannot be excluded. For example, apoptotic mechanisms leading
to the loss of gallbladder TCs should be considered. The apoptosis
might be caused by multiple mechanisms, including chronic inflam-
matory reactions [65], and it is possible that the reduced number of
TCs in the inflamed gallbladder wall in patients with gallstones could
be caused by an imbalance between the apoptosis and regeneration
of TCs. Finally, the reduced number of TCs might be primarily caused
by the trans-differentiation of TCs precursor cells, as reported by Tor-
ihashi et al. in the smooth muscles in the gut [66].
This study established that altered bile composition in patients
with cholelithiasis may influence TCs within the gallbladder muscle.
We conclude that a reduction in TC number may be a consequence of
the toxicity of the supersaturated bile, while some other bile compo-
nents (glycocholic and taurocholic acids) may exert protective effects
on TCs and thus possibly influence the mechanisms regulating
gallbladder and extrahepatic bile duct motility.
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